In addition, an increasing promoter CpG dinucleotide methylation frequency was observed in case of SOCS1 gene in accelerated and blastic phases of the CML disease than chronic phase but the differences did not reach statistical significance. The gene discussed is SOCS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.